X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (85317) 85317
Newsletter (3568) 3568
Newspaper Article (3179) 3179
Magazine Article (820) 820
Book Chapter (276) 276
Book / eBook (272) 272
Dissertation (134) 134
Web Resource (94) 94
Book Review (66) 66
Transcript (50) 50
Trade Publication Article (40) 40
Reference (37) 37
Conference Proceeding (35) 35
Government Document (24) 24
Paper (23) 23
Report (22) 22
Publication (9) 9
Streaming Video (4) 4
Journal / eJournal (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (73985) 73985
female (42807) 42807
male (41564) 41564
adult (39233) 39233
hiv infections - complications (37513) 37513
hiv (34139) 34139
middle aged (23642) 23642
infectious diseases (22963) 22963
human immunodeficiency virus--hiv (19254) 19254
aids (17213) 17213
risk factors (17014) 17014
hiv infections - drug therapy (16949) 16949
hiv infection (16827) 16827
immunology (14476) 14476
health aspects (12116) 12116
adolescent (11145) 11145
pregnancy (10651) 10651
prevalence (10453) 10453
hiv infections - epidemiology (10312) 10312
research (9576) 9576
human-immunodeficiency-virus (9220) 9220
infection (9113) 9113
infections (9012) 9012
antiretroviral therapy (8602) 8602
acquired immune deficiency syndrome--aids (8306) 8306
hiv patients (7782) 7782
young adult (7644) 7644
care and treatment (7549) 7549
aged (7331) 7331
human immunodeficiency virus (7206) 7206
hiv infections - transmission (7018) 7018
anti-hiv agents - therapeutic use (7010) 7010
drug therapy (6805) 6805
virology (6579) 6579
diagnosis (6354) 6354
medicine, general & internal (6281) 6281
mortality (6206) 6206
public, environmental & occupational health (6170) 6170
cd4 lymphocyte count (6063) 6063
microbiology (6006) 6006
hiv-1 (5971) 5971
child (5783) 5783
prevention (5714) 5714
hiv infections - immunology (5707) 5707
hiv infections - prevention & control (5704) 5704
retrospective studies (5604) 5604
tuberculosis (5561) 5561
complications and side effects (5487) 5487
antiviral agents (5410) 5410
aids/hiv (5348) 5348
treatment outcome (5324) 5324
disease (5272) 5272
highly active antiretroviral therapy (5207) 5207
risk (5192) 5192
cross-sectional studies (5091) 5091
research article (5056) 5056
antiretroviral therapy, highly active (4991) 4991
epidemiology (4976) 4976
analysis (4957) 4957
prospective studies (4942) 4942
hiv infections - virology (4932) 4932
cohort studies (4902) 4902
viral load (4882) 4882
virus diseases (4869) 4869
infant, newborn (4844) 4844
complications (4819) 4819
hiv infections - diagnosis (4737) 4737
infant (4652) 4652
medicine (4615) 4615
acquired immunodeficiency syndrome - complications (4601) 4601
women (4467) 4467
patients (4320) 4320
public health (4133) 4133
hiv/aids (4107) 4107
incidence (3995) 3995
antiretroviral drugs (3973) 3973
active antiretroviral therapy (3933) 3933
medical research (3877) 3877
substance abuse, intravenous - complications (3846) 3846
child, preschool (3812) 3812
therapy (3760) 3760
viruses (3757) 3757
hiv-infection (3723) 3723
animals (3675) 3675
hiv seropositivity - complications (3504) 3504
children (3461) 3461
studies (3221) 3221
hepatitis (3209) 3209
infectious disease transmission, vertical - prevention & control (3194) 3194
risk-factors (3101) 3101
acquired immune deficiency syndrome (3068) 3068
medicine & public health (3045) 3045
hiv infections (3037) 3037
hiv infections - psychology (3025) 3025
hepatitis c (2975) 2975
hepatitis c - complications (2903) 2903
usage (2903) 2903
transmission (2877) 2877
disease transmission (2818) 2818
sexual behavior (2789) 2789
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (141) 141
Online Resources - Online (75) 75
Collection Dvlpm't (Acquisitions) - Vendor file (22) 22
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
New College (Ivey) - Stacks (7) 7
Robarts - Stacks (6) 6
UofT at Scarborough - Stacks (5) 5
St. Michael's Hospital - Stacks (4) 4
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (3) 3
Humber River Regional Hospital - Finch Stacks (3) 3
Lakeridge Health Sciences - Oshawa (3) 3
UofT at Mississauga - Stacks (3) 3
Gerstein Science - Circulation Desk (2) 2
Gerstein Science - Periodical Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
Toronto East General Hospital - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
University College (Laidlaw) - Stacks (2) 2
Women's College Hospital - Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Law (Bora Laskin) - Theses (1) 1
Media Commons - Microtexts (1) 1
Providence Healthcare - Reference (1) 1
Robarts - Government Pubs (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - Online (1) 1
Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (88384) 88384
French (1805) 1805
Spanish (1750) 1750
German (678) 678
Portuguese (298) 298
Russian (275) 275
Japanese (223) 223
Italian (218) 218
Chinese (172) 172
Dutch (116) 116
Polish (96) 96
Danish (50) 50
Swedish (42) 42
Norwegian (41) 41
Czech (37) 37
Turkish (32) 32
Hungarian (27) 27
Hebrew (25) 25
Romanian (21) 21
Croatian (14) 14
Serbian (12) 12
Korean (10) 10
Finnish (9) 9
Bulgarian (5) 5
Persian (5) 5
Afrikaans (4) 4
Arabic (4) 4
Ukrainian (4) 4
Lithuanian (2) 2
Greek (1) 1
Hindi (1) 1
Icelandic (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 76, Issue 3, pp. 538 - 550
... infections, are well described in the pediatric population.1-3 Few data exist in adults regarding these eruptions or how to differentiate between different viruses... 
Dermatology | viruses | serology | laboratory tests | morbilliform eruption | Cost-effectiveness | polymerase chain reaction | viral antigen tests | CHAIN-REACTION ASSAY | HUMAN-HERPESVIRUS 6 | ATYPICAL EXANTHEMS | RENAL-TRANSPLANTATION | DERMATOLOGY | REAL-TIME PCR | WHOLE-BLOOD | CONTINENTAL UNITED-STATES | MOUTH-DISEASE | CYTOMEGALOVIRUS ANTIGENEMIA | EPSTEIN-BARR-VIRUS | Exanthema - virology | Infectious Mononucleosis - complications | Chikungunya Fever - diagnosis | Measles - diagnosis | Clinical Laboratory Techniques | Humans | Roseolovirus Infections - diagnosis | Cytomegalovirus Infections - complications | Infectious Mononucleosis - diagnosis | Virus Diseases - complications | Parvoviridae Infections - diagnosis | Rubella - diagnosis | Chikungunya Fever - complications | HIV Infections - diagnosis | Rubella - complications | Zika Virus Infection - complications | Adult | Parvoviridae Infections - complications | Respiratory Tract Infections - complications | Coxsackievirus Infections - diagnosis | Cytomegalovirus Infections - diagnosis | Echovirus Infections - diagnosis | Respiratory Tract Infections - diagnosis | Coxsackievirus Infections - complications | Dengue - complications | Zika Virus Infection - diagnosis | Virus Diseases - diagnosis | Echovirus Infections - complications | HIV Infections - complications | Measles - complications | Roseolovirus Infections - complications | Exanthema Subitum - diagnosis | Dengue - diagnosis | Medical colleges | Adults | Epstein-Barr virus | Foot-and-mouth disease | Coxsackievirus infections | Viral antigens
Journal Article
PLOS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0158090
Background Hepatitis B (HBV), hepatitis C (HCV) and other sexually transmitted infections (STIs... 
MORTALITY | B-VIRUS | WOMEN | RISK-FACTORS | HEPATITIS-C VIRUS | SEMEN | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL THERAPY | COHORT | HUMAN-PAPILLOMAVIRUS INFECTION | EPIDEMIOLOGY | Virus Diseases - epidemiology | Prevalence | Cytomegalovirus Infections - epidemiology | HIV Infections - epidemiology | Humans | Middle Aged | Hepatitis B - epidemiology | Male | Sexually Transmitted Diseases - epidemiology | Cytomegalovirus Infections - complications | Virus Diseases - complications | Sexually Transmitted Diseases - complications | Hepatitis B - complications | Bacterial Infections - complications | Homosexuality, Male | Hepatitis C - epidemiology | Adult | Hepatitis C - complications | Surveys and Questionnaires | Gonorrhea - epidemiology | Papillomavirus Infections - complications | Sexual Behavior | Papillomavirus Infections - epidemiology | Chlamydia Infections - complications | Syphilis - epidemiology | Chlamydia Infections - epidemiology | Coinfection - epidemiology | Disease Progression | Bacterial Infections - epidemiology | HIV Infections - complications | Ontario - epidemiology | Herpes Simplex - complications | Gonorrhea - complications | Sexual Partners | Syphilis - complications | Herpes Simplex - epidemiology | Sexually transmitted diseases | Demographic aspects | Sexual behavior | Research | Gay men | Risk factors | HIV seropositivity | Diseases | Drug abuse | Sexually transmitted diseases--STD | Laboratories | Sex | Herpes simplex | Viruses | Infections | Serology | Hepatitis | Human papillomavirus | Acquired immune deficiency syndrome--AIDS | Chlamydia | Syphilis | Health care networks | Human immunodeficiency virus--HIV | Hepatitis B virus | Public health | Urine | Cytomegalovirus | Bacterial infections | Health risks | Gonorrhea | Medicine | Disease transmission | Womens health | Herpes viruses | Men | Hepatitis C virus | Hepatitis C | Health risk assessment | Native North Americans | Sexual partners | Hepatitis B | STD | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
1998, Blackwell companions to philosophy., ISBN 0631197370, xv, 512
Book
Primary Care - Clinics in Office Practice, ISSN 0095-4543, 09/2018, Volume 45, Issue 3, pp. 567 - 586
... complications, and require treatments that are safe in pregnancy. Infections such as hepatitis B and C and human immunodeficiency virus can be transmitted vertically and therefore management focuses on decreasing perinatal transmission... 
TORCH | Vertical transmission | Pregnancy complications | Congenital infection | Zika | UNITED-STATES | URINARY-TRACT-INFECTIONS | TO-INFANT TRANSMISSION | DISEASES-TREATMENT-GUIDELINES | BIRTH-DEFECTS-PREVENTION | MEDICINE, GENERAL & INTERNAL | HERPES-SIMPLEX-VIRUS | HEPATITIS-C VIRUS | NEISSERIA-GONORRHOEAE INFECTION | PRIMARY HEALTH CARE | ZIKA VIRUS | INFLUENZA-A H1N1 | Chlamydia Infections - therapy | Toxoplasmosis - therapy | Vaginitis - diagnosis | Humans | Influenza, Human - complications | Urinary Tract Infections - complications | Virus Diseases - complications | Toxoplasmosis - complications | Syphilis - diagnosis | HIV Infections - diagnosis | Female | Gonorrhea - diagnosis | Influenza, Human - diagnosis | Influenza, Human - therapy | Vaginitis - therapy | Pregnancy Complications, Infectious - diagnosis | Urinary Tract Infections - diagnosis | Chlamydia Infections - diagnosis | Toxoplasmosis - diagnosis | Virus Diseases - therapy | Chlamydia Infections - complications | Gonorrhea - therapy | Infectious Disease Transmission, Vertical | Syphilis - therapy | Pregnancy | Vaginitis - complications | Virus Diseases - diagnosis | HIV Infections - complications | HIV Infections - therapy | Urinary Tract Infections - therapy | Gonorrhea - complications | Syphilis - complications | Pregnancy Complications, Infectious - therapy
Journal Article
Seminars in Hematology, ISSN 0037-1963, 2010, Volume 47, Issue 2, pp. 187 - 198
After more than 10 years of use, rituximab has proven to be remarkably safe. However, accumulated evidence now suggests that under some circumstances it may significantly increase the risk of infections... 
Hematology, Oncology and Palliative Medicine | RHEUMATOID-ARTHRITIS | PATIENTS RECEIVING RITUXIMAB | PHASE-II TRIAL | HEPATITIS-B-VIRUS | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | MANTLE CELL LYMPHOMA | PNEUMOCYSTIS-JIROVECII PNEUMONIA | NON-HODGKINS-LYMPHOMA | CHRONIC LYMPHOCYTIC-LEUKEMIA | HIGH-DOSE CHEMOTHERAPY | HEMATOLOGY | Lymphoma, Non-Hodgkin - immunology | Pneumonia, Pneumocystis - etiology | JC Virus - immunology | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | JC Virus - physiology | Postoperative Complications - immunology | Infection - etiology | Parvovirus B19, Human - immunology | Meningoencephalitis - immunology | Hepatitis B - complications | Hepatitis B - immunology | Enterovirus Infections - virology | Lymphoma, Non-Hodgkin - complications | Antineoplastic Agents - adverse effects | Parvovirus B19, Human - physiology | Antineoplastic Agents - pharmacology | Hepatitis B virus - immunology | Immunosuppressive Agents - pharmacology | Postoperative Complications - chemically induced | Autoimmune Diseases - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Leukoencephalopathy, Progressive Multifocal - immunology | Enterovirus Infections - etiology | Antibodies, Monoclonal, Murine-Derived | Disease Susceptibility | Infection - immunology | Antibodies, Monoclonal - pharmacology | Graft Rejection - prevention & control | Risk Factors | Autoimmune Diseases - complications | Autoimmune Diseases - immunology | Rituximab | Hepatitis B virus - physiology | Virus Activation - drug effects | Meningoencephalitis - virology | HIV Infections - complications | Immunosuppressive Agents - adverse effects | Immunocompromised Host | Leukoencephalopathy, Progressive Multifocal - complications
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 5/2014, Volume 58, Issue 9, pp. 1308 - 1311
... of Opportunistic Infections in HIV-Infected Adults and Adolescents was released online. These guidelines, since their inception in 1989, have been widely accessed in the United States and abroad... 
Antiretrovirals | HIV infections | Tuberculosis | Opportunistic infections | Infectious diseases | HIV | VIEWPOINTS | Xeroderma pigmentosum | AIDS | Preventive medicine | Adolescents | HIV/AIDS | opportunistic infections | online | guideline | revision | MORTALITY | INFECTIOUS DISEASES | RISK-FACTORS | TUBERCULOSIS | MICROBIOLOGY | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | TRENDS | MENINGITIS | RECONSTITUTION INFLAMMATORY SYNDROME | RECOMMENDATIONS | BENEFITS | Immune Reconstitution Inflammatory Syndrome - prevention & control | Hepatitis C - drug therapy | United States | Humans | Tuberculosis - complications | Hepatitis B - complications | National Institutes of Health (U.S.) | Tuberculosis - drug therapy | Adult | Hepatitis C - complications | Hepatitis C - prevention & control | Papillomavirus Infections - complications | Immune Reconstitution Inflammatory Syndrome - complications | AIDS-Related Opportunistic Infections - drug therapy | Centers for Disease Control and Prevention (U.S.) | AIDS-Related Opportunistic Infections - prevention & control | Papillomavirus Infections - prevention & control | Tuberculosis - prevention & control | Adolescent | HIV Infections - complications | Hepatitis B - drug therapy | Immune Reconstitution Inflammatory Syndrome - drug therapy | Papillomavirus Infections - drug therapy | HIV Infections - drug therapy | Hepatitis B - prevention & control
Journal Article
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 04/2011, Volume 25, Issue 2, pp. 241 - 259
Anemia in pregnancy is a global health problem affecting nearly half of all pregnant women worldwide. High fetal demands for iron render iron deficiency the... 
Pregnancy | Iron deficiency | Anemia | B12 deficiency | Folate | INEFFECTIVE ERYTHROPOIESIS | SULFADOXINE-PYRIMETHAMINE | IRON-DEFICIENCY ANEMIA | FOLIC-ACID | HEMOGLOBIN-H DISEASE | WOMEN | PERINATAL OUTCOMES | MEDICAL PROGRESS | ONCOLOGY | HOMOZYGOUS ALPHA-THALASSEMIA | B-12 deficiency | SICKLE-CELL-DISEASE | HEMATOLOGY | Pregnancy Complications, Neoplastic - diagnosis | Pre-Eclampsia - epidemiology | Anemia - epidemiology | HIV Infections - epidemiology | Humans | Hookworm Infections - epidemiology | Pregnancy Complications, Neoplastic - metabolism | Sepsis - diagnosis | Sepsis - complications | Hookworm Infections - complications | Malaria - epidemiology | Sepsis - metabolism | HIV Infections - diagnosis | Female | Pre-Eclampsia - metabolism | Pregnancy Complications, Hematologic - diagnosis | Malaria - metabolism | Anemia - etiology | Pre-Eclampsia - diagnosis | Anemia - diagnosis | Sepsis - epidemiology | Hemoglobins - metabolism | Hookworm Infections - metabolism | Malaria - diagnosis | Pregnancy Complications, Neoplastic - epidemiology | Hookworm Infections - diagnosis | Pregnancy Complications, Parasitic - metabolism | Plasma Volume | Anemia - metabolism | HIV Infections - complications | Pregnancy Complications, Parasitic - diagnosis | Malaria - complications | Pregnancy Complications, Hematologic - metabolism | Pregnancy Complications, Parasitic - epidemiology | Pregnancy Complications, Hematologic - etiology | Pregnancy Complications, Hematologic - epidemiology | HIV Infections - metabolism
Journal Article
Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 11, pp. 1904 - 1911
Immune checkpoint inhibitors, including those targeting the programmed cell death 1/programmed cell death ligand 1 and cytotoxic T lymphocyte antigen 4... 
pembrolizumab | autoimmune | nivolumab | elderly | ipilimumab | pediatrics | pregnancy | transplant | organ dysfunction | ALLOGRAFT-REJECTION | PERFORMANCE STATUS | PD-1 BLOCKADE | OPEN-LABEL | CELL LUNG-CANCER | IPILIMUMAB THERAPY | ONCOLOGY | ADVANCED MELANOMA | BRAIN METASTASES | AUTOIMMUNE-DISEASE | T-CELLS | Lung Neoplasms - drug therapy | Melanoma - complications | Age Factors | Humans | Immunosuppressive Agents - therapeutic use | Ipilimumab | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Hepatitis C, Chronic - complications | Transplant Recipients | Neoplasms - complications | Brain Neoplasms - secondary | Squamous Cell Carcinoma of Head and Neck | Pregnancy Complications, Neoplastic - drug therapy | Female | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - complications | Graft Rejection - prevention & control | Autoimmune Diseases - complications | Head and Neck Neoplasms - drug therapy | Brain Neoplasms - drug therapy | Lung Neoplasms - complications | Neoplasms - drug therapy | Pregnancy | Carcinoma, Non-Small-Cell Lung - complications | B7-H1 Antigen - antagonists & inhibitors | Carcinoma, Squamous Cell - drug therapy | Hepatitis B, Chronic - complications | Carcinoma, Squamous Cell - complications | Melanoma - drug therapy | Nivolumab | HIV Infections - complications | Head and Neck Neoplasms - complications | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Renal Cell - complications | Immunocompromised Host | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Virus diseases | Care and treatment | Dosage and administration | Research | Cell death | Immunosuppressive agents | Medical research | Brain | Populations | Toxicity | Decision making | Mortality | Disorders | Clinical trials | Cytotoxicity | Lymphocytes T | Metastasis | Patients | Regulatory approval | Metastases | Inhibitors | Immune checkpoint | Aggregates | Lymphocytes | Safety | Autoimmune diseases | Cancer | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 1537-6613, 2013, Volume 207, Issue 1, pp. 9 - 17
Background. Extensively drug-resistant tuberculosis (XDR-tuberculosis) is a global public health threat, but few data exist elucidating factors driving this... 
Epidemics | Ferries | BACTERIA | Tuberculosis | Disease transmission | Mycobacterium tuberculosis | HIV | Hospital admissions | Data transmission | Multidrug resistant tuberculosis | Infection control | Genotyping | Drug resistance | Transmission | MYCOBACTERIUM-TUBERCULOSIS | INFECTIOUS DISEASES | tuberculosis | genotyping | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | CARE | transmission | NEW-YORK-CITY | INFECTED PATIENTS | drug resistance | XDR-TB | OUTBREAK | SPREAD | STRAIN | EPIDEMIOLOGY | Prevalence | Humans | Male | Cross Infection - complications | Cross Infection - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | Cross Infection - epidemiology | Extensively Drug-Resistant Tuberculosis - complications | Mycobacterium tuberculosis - classification | HIV Infections - virology | South Africa - epidemiology | Genotype | Sequence Analysis, DNA | Mycobacterium tuberculosis - isolation & purification | Pyrazinamide - therapeutic use | Extensively Drug-Resistant Tuberculosis - epidemiology | Hospitals, Rural | Polymorphism, Restriction Fragment Length | Extensively Drug-Resistant Tuberculosis - transmission | Cross Infection - microbiology | HIV Infections - complications | Mutation | Cluster Analysis | Mycobacterium tuberculosis - genetics | Extensively drug-resistant tuberculosis | Distribution | Reports | Cross infection | Research | Nosocomial infections | Risk factors | Major and Brief Reports
Journal Article